Mount Laurel, NJ, July 25, 2005 – Charles DePrince, president of FCI Health Science, Inc. announced today the introduction of a new name for the company. Effective immediately, FCI Health Science, Inc. will be known as Fuji Health Science, Inc.
According to DePrince, “It is a simple name change but one we felt necessary to clearly establish the connection to our parent company, Fuji Chemical Industry Co., Ltd., of Toyama, Japan.”
Fuji Chemical is a 60 year old global supplier of unique and functional ingredients to the pharmaceutical and personal care industries as well as a leading supplier of natural and high purity ingredients to the dietary supplement market. Fuji Health Science is Fuji Chemical Industry’s United States subsidiary responsible for marketing its products throughout North and South America.
“The newest, and one of the most exciting products Fuji offers, is AstaREAL®, the natural form of astaxanthin from the single cell green microalgae, haematococcus pluvialis,” DePrince added.
Astaxanthin is one of nature’s most powerful antioxidants. It is 550 times more effective than vitamin E at quenching singlet oxygen and 10 times more effective than other carotenoids at inhibiting lipid peroxidation. This power gives it the potential for supporting many health benefits.
Fuji is the leading producer of natural astaxanthin for human nutritional use in the world with state of the art cultivation and production facilities in Maui, Hawaii and Gustavsberg, Sweden. Fuji’s astaxanthin products, AstaREAL® and AstaCarox®, are approved for use in nutritional supplementation in the U.S., Europe, and Japan, as well as other markets worldwide.
For more information, contact: